What are the major opportunities in the Osteoarthritis Therapeutics market? What are the strategies for the Osteoarthritis Therapeutics market?

For detailed insights on the major opportunities and strategies in the Osteoarthritis Therapeutics market, Read More

How does the Osteoarthritis Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Osteoarthritis Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Osteoarthritis Therapeutics market growth? SWOT analysis of the Osteoarthritis Therapeutics market.

For detailed insights on the key dynamics influencing the Osteoarthritis Therapeutics market growth and SWOT analysis of the Osteoarthritis Therapeutics industry, Read More

Global Osteoarthritis Therapeutics Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Osteoarthritis Therapeutics Global Market Report 2025

Name: Osteoarthritis Therapeutics Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Drug Type (Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Other Drug Types), By Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies), By Route Of Administration (Parenteral Route, Topical Route, Oral Route), By Sales Channel (Prescription Drugs, Over-the-Counter Drugs), By End-use (Hospital Pharmacies, Retail Pharmacies, Other End-uses) – Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Osteoarthritis Therapeutics Market?

Osteoarthritis therapeutics refer to the medical treatments and interventions used to manage and alleviate the symptoms of osteoarthritis, a degenerative joint disease characterized by the breakdown of cartilage and the underlying bone. These therapeutics include medications, physical therapies, lifestyle modifications, and in some cases, surgical procedures. The primary goals of osteoarthritis therapeutics are to reduce pain, improve joint function, and enhance the quality of life for individuals affected by the condition.

The main drug types of osteoarthritis therapeutics are viscosupplementation agents, nonsteroidal anti-inflammatory drugs, analgesics, corticosteroids, and others. Viscosupplementation agents are treatments injected directly into the joint to help lubricate and cushion it, providing relief from pain and improving mobility. The anatomy includes knee osteoarthritis, hip osteoarthritis, hand osteoarthritis, and others, and the different routes of administration are parenteral route, topical route, and oral route. The various sales channels are prescription drugs and over-the-counter drugs, and they are used by various end-users such as hospital pharmacies, retail pharmacies, and others.

Osteoarthritis Therapeutics Market Size and growth rate 2025 to 2029: Graph

What Is The Osteoarthritis Therapeutics Market Size 2025 And Growth Rate?

The osteoarthritis therapeutics market size has grown strongly in recent years. It will grow from $8.17 billion in 2024 to $8.87 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to an aging population, advancements in drug delivery systems, increasing awareness and diagnosis, development of novel therapies, and rising obesity rates.

What Is The Osteoarthritis Therapeutics Market Growth Forecast?

The osteoarthritis therapeutics market size is expected to see strong growth in the next few years. It will grow to $12.22 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising obesity rates, advancements in treatment modalities, increasing awareness and diagnosis, development of disease-modifying osteoarthritis drugs (DMOADs), and government and private funding for research. Major trends in the forecast period include increasing focus on personalized medicine, the emergence of regenerative therapies, the expansion of pain management options, government and regulatory support, and rising demand in emerging markets.

Book your 30 minutes free consultation with our research experts

How Is The Osteoarthritis Therapeutics Market Segmented?

The osteoarthritis therapeuticsmarket covered in this report is segmented –

1) Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Other Drug Types

2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies

3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route

4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs

5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-uses

Subsegments:

1) Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products

2) Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors

3) Analgesics: Opioid Analgesics, Non-Opioid Analgesics, Topical Analgesics

4) Corticosteroids: Injectable Corticosteroids, Oral Corticosteroids, Intra-Articular Corticosteroids

5) Other Drug Types: Disease-Modifying Osteoarthritis Drugs (DMOADs), Platelet-Rich Plasma Therapy, Stem Cell Therapy

What Is Driving The Osteoarthritis Therapeutics Market? Rising Sports Injuries Fuel Growth In Osteoarthritis Therapeutics Market

Rising sports injuries are expected to propel the growth of the osteoarthritis therapeutics market. A sports injury refers to any injury or harm that occurs during sports or athletic activities. These injuries can range in severity from small to severe, and they can affect various body parts. The increase in sports injuries is largely due to the rising participation in sports activities and the growing intensity and competitiveness of these activities. Osteoarthritis therapeutics are used in sports injuries to manage pain and inflammation and to improve joint function in athletes suffering from joint degeneration. For instance, in 2022, according to the National Safety Council, a US-based nonprofit, public service organization promoting health and safety, the incidence of sports and recreational injuries reported in 2022 rose by 12%. Therefore, rising sports injuries are driving the growth of the osteoarthritis therapeutics market.

Who Are The Major Players In The Global Osteoarthritis Therapeutics Market?

Major companies operating in the osteoarthritis therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Zimmer Biomet Holdings Inc., Horizon Therapeutics plc, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Galapagos NV, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Samumed LLC, Orthogen AG, Kolon Life Science Inc.

What Are The Key Trends Of The Global Osteoarthritis Therapeutics Market? Innovative Advances In Osteoarthritis Therapeutics With The Launch Of The NITRO Program

Major companies operating in the osteoarthritis therapeutics market are focused on developing innovative solutions, such as novel innovations for tissue regeneration in osteoarthritis. Tissue regeneration in osteoarthritis refers to the process of repairing or replacing damaged cartilage and joint tissues to restore normal function and alleviate pain. For instance, in May 2023, the Advanced Research Projects Agency for Health (ARPA-H), a US-based government agency, launched the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO). The Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program, initiated by the Advanced Research Projects Agency for Health (ARPA-H), focuses on developing cutting-edge injectable therapies that stimulate cartilage repair by leveraging biological pathways similar to those active during embryonic development. Unique features include a collaborative multimodal approach among research teams and advanced testing techniques such as "joint-on-a-chip" platforms to mimic joint environments, aiming to create regenerative solutions that address the underlying causes of osteoarthritis.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Osteoarthritis Therapeutics Market? Juniper Biologics Acquires Licensing Rights To TG-C LD For Knee Osteoarthritis Treatment

In April 2022, Juniper Biologics Pte Ltd, a Singapore-based pharmaceutical company, acquired the licensing rights to TG-C LD (TissueGene-C low dose) from Kolon Life Science for $600 million. By acquiring the rights to TG-C LD, Juniper Biologics positions itself as a leader in the emerging field of cell-mediated gene therapies, specifically targeting knee osteoarthritis, which is a major unmet medical need affecting approximately 300 million patients across the Asia-Pacific, Middle East, and Africa. Kolon Life Science Inc. is a South Korea-based provider of osteoarthritis therapeutics.

What Is The Regional Outlook For The Global Osteoarthritis Therapeutics Market?

North America was the largest region in the osteoarthritis therapeutics market in 2022. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the osteoarthritis therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Osteoarthritis Therapeutics Market?

The osteoarthritis therapeutics market consists of revenues earned by entities by providing services such as exercises and therapies, diagnostic services, and pain management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The osteoarthritis therapeutics market also includes sales of pain relievers, corticosteroids, hyaluronic acid injections, and assistive devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Osteoarthritis Therapeutics Industry?

The osteoarthritis therapeutics market research report is one of a series of new reports from The Business Research Company that provides osteoarthritis therapeutics market statistics, including osteoarthritis therapeutics industry global market size, regional shares, competitors with a osteoarthritis therapeutics market share, detailed osteoarthritis therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the osteoarthritis therapeutics industry. This osteoarthritis therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Osteoarthritis Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$8.87 billion
Revenue Forecast In 2034	$12.22 billion
Growth Rate	CAGR of 8.3% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Other Drug Types 2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies 3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route 4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs 5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-uses Subsegments: 1) Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products 2) Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors 3) Analgesics: Opioid Analgesics, Non-Opioid Analgesics, Topical Analgesics 4) Corticosteroids: Injectable Corticosteroids, Oral Corticosteroids, Intra-Articular Corticosteroids 5) Other Drug Types: Disease-Modifying Osteoarthritis Drugs (DMOADs), Platelet-Rich Plasma Therapy, Stem Cell Therapy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Zimmer Biomet Holdings Inc., Horizon Therapeutics plc, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Galapagos NV, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Samumed LLC, Orthogen AG, Kolon Life Science Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Osteoarthritis Therapeutics Market Characteristics

3. Osteoarthritis Therapeutics Market Trends And Strategies

4. Osteoarthritis Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Osteoarthritis Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Osteoarthritis Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Osteoarthritis Therapeutics Market Growth Rate Analysis

5.4. Global Osteoarthritis Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Osteoarthritis Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Osteoarthritis Therapeutics Total Addressable Market (TAM)

6. Osteoarthritis Therapeutics Market Segmentation

6.1. Global Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viscosupplementation Agents

Nonsteroidal Anti-inflammatory Drugs

Analgesics

Corticosteroids

Other Drug Types

6.2. Global Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Knee Osteoarthritis

Hip Osteoarthritis

Hand Osteoarthritis

Other Anatomies

6.3. Global Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Parenteral Route

Topical Route

Oral Route

6.4. Global Osteoarthritis Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prescription Drugs

Over-the-Counter Drugs

6.5. Global Osteoarthritis Therapeutics Market, Segmentation By End-use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Other End-uses

6.6. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Viscosupplementation Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hyaluronic Acid Injections

Single-Injection Products

Multi-Injection Products

6.7. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Nonsteroidal Anti-inflammatory Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral NSAIDs

Topical NSAIDs

COX-2 Inhibitors

6.8. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Opioid Analgesics

Non-Opioid Analgesics

Topical Analgesics

6.9. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable Corticosteroids

Oral Corticosteroids

Intra-Articular Corticosteroids

6.10. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Disease-Modifying Osteoarthritis Drugs (DMOADs)

Platelet-Rich Plasma Therapy

Stem Cell Therapy

7. Osteoarthritis Therapeutics Market Regional And Country Analysis

7.1. Global Osteoarthritis Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Osteoarthritis Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Osteoarthritis Therapeutics Market

8.1. Asia-Pacific Osteoarthritis Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Osteoarthritis Therapeutics Market

9.1. China Osteoarthritis Therapeutics Market Overview

9.2. China Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Osteoarthritis Therapeutics Market

10.1. India Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Osteoarthritis Therapeutics Market

11.1. Japan Osteoarthritis Therapeutics Market Overview

11.2. Japan Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Osteoarthritis Therapeutics Market

12.1. Australia Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Osteoarthritis Therapeutics Market

13.1. Indonesia Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Osteoarthritis Therapeutics Market

14.1. South Korea Osteoarthritis Therapeutics Market Overview

14.2. South Korea Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Osteoarthritis Therapeutics Market

15.1. Western Europe Osteoarthritis Therapeutics Market Overview

15.2. Western Europe Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Osteoarthritis Therapeutics Market

16.1. UK Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Osteoarthritis Therapeutics Market

17.1. Germany Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Osteoarthritis Therapeutics Market

18.1. France Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Osteoarthritis Therapeutics Market

19.1. Italy Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Osteoarthritis Therapeutics Market

20.1. Spain Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Osteoarthritis Therapeutics Market

21.1. Eastern Europe Osteoarthritis Therapeutics Market Overview

21.2. Eastern Europe Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Osteoarthritis Therapeutics Market

22.1. Russia Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Osteoarthritis Therapeutics Market

23.1. North America Osteoarthritis Therapeutics Market Overview

23.2. North America Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Osteoarthritis Therapeutics Market

24.1. USA Osteoarthritis Therapeutics Market Overview

24.2. USA Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Osteoarthritis Therapeutics Market

25.1. Canada Osteoarthritis Therapeutics Market Overview

25.2. Canada Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Osteoarthritis Therapeutics Market

26.1. South America Osteoarthritis Therapeutics Market Overview

26.2. South America Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Osteoarthritis Therapeutics Market

27.1. Brazil Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Osteoarthritis Therapeutics Market

28.1. Middle East Osteoarthritis Therapeutics Market Overview

28.2. Middle East Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Osteoarthritis Therapeutics Market

29.1. Africa Osteoarthritis Therapeutics Market Overview

29.2. Africa Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Osteoarthritis Therapeutics Market Competitive Landscape And Company Profiles

30.1. Osteoarthritis Therapeutics Market Competitive Landscape

30.2. Osteoarthritis Therapeutics Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Osteoarthritis Therapeutics Market Other Major And Innovative Companies

31.1. Sanofi S.A.

31.2. Bristol-Myers Squibb Company

31.3. Novartis AG

31.4. GlaxoSmithKline plc

31.5. Medtronic plc

31.6. Eli Lilly and Company

31.7. Gilead Sciences Inc.

31.8. Teva Pharmaceutical Industries Ltd.

31.9. Regeneron Pharmaceuticals Inc.

31.10. Daiichi Sankyo Company Limited

31.11. Zimmer Biomet Holdings Inc.

31.12. Horizon Therapeutics plc

31.13. Taisho Pharmaceutical Co. Ltd.

31.14. Ferring Pharmaceuticals

31.15. Galapagos NV

32. Global Osteoarthritis Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Osteoarthritis Therapeutics Market

34. Recent Developments In The Osteoarthritis Therapeutics Market

35. Osteoarthritis Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Osteoarthritis Therapeutics Market In 2029 - Countries Offering Most New Opportunities

35.2 Osteoarthritis Therapeutics Market In 2029 - Segments Offering Most New Opportunities

35.3 Osteoarthritis Therapeutics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Osteoarthritis Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Osteoarthritis Therapeutics Market, Segmentation By End-use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Viscosupplementation Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Nonsteroidal Anti-inflammatory Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Osteoarthritis Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Osteoarthritis Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Pfizer Inc. Financial Performance

Table 82: Johnson & Johnson Financial Performance

Table 83: Merck & Co. Inc. Financial Performance

Table 84: AbbVie Inc. Financial Performance

Table 85: Bayer AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Osteoarthritis Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Osteoarthritis Therapeutics Market, Segmentation By End-use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Viscosupplementation Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Nonsteroidal Anti-inflammatory Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Osteoarthritis Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Osteoarthritis Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Pfizer Inc. Financial Performance

Figure 82: Johnson & Johnson Financial Performance

Figure 83: Merck & Co. Inc. Financial Performance

Figure 84: AbbVie Inc. Financial Performance

Figure 85: Bayer AG Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Neurodegenerative Disorder Therapeutics Global Market Report 2025 – By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N- methyl- ...

Respiratory Devices And Equipment (Therapeutic) Global Market Report 2025 – By Product (Nebulizers, Humidifiers, Oxygen Concentrators, Positive Airway Pressure Devices, Ventilators, Capnographs, Gas Analyzers), By Techno...

Antisense & RNAi Therapeutics Global Market Report 2025 – By Technology (RNA Interference, Antisense RNA), By Route of Administration (Intravenous Injections, Intra-dermal Injections, Other Delivery Methods), By Indicati...

Biosimilar Therapeutic Peptides Global Market Report 2025 – By Type (Innovative, Generic), By Route Of Administration (Parenteral Route, Transdermal Route, Other Route Of Administrations), By Application (Cancer, Cardiov...

Leukemia Therapeutics Global Market Report 2025 – By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments), By Type Of Leukemia (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymp...

Bipolar Disorder Therapeutics Global Market Report 2025 – By Drug Class (Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs), By Mechanism (Selective Serotonin Reuptake Inhibitors, Serotonin-norepin...

Peptide Therapeutics Global Market Report 2025 – By Type (Generic, Branded), By Route of Administration (Parenteral, Mucosal, Oral, Transdermal), By Application (Cancer, Cardiovascular Diseases, Central Nervous Systems, ...

Frequently Asked Questions

What is the definition of the Osteoarthritis Therapeutics market?

How will the Osteoarthritis Therapeutics market drivers and restraints affect the market dynamics? What forces will shape the Osteoarthritis Therapeutics industry going forward?

The Osteoarthritis Therapeutics market major growth driver - Rising Sports Injuries Fuel Growth In Osteoarthritis Therapeutics Market. For further insights on the Osteoarthritis Therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the Osteoarthritis Therapeutics market?

The Osteoarthritis Therapeutics market size has grown strongly in recent years. The osteoarthritis therapeutics market size has grown strongly in recent years. It will grow from $8.17 $ billion in 2024 to $8.87 $ billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to an aging population, advancements in drug delivery systems, increasing awareness and diagnosis, development of novel therapies, and rising obesity rates. The osteoarthritis therapeutics market size is expected to see strong growth in the next few years. It will grow to $12.22 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising obesity rates, advancements in treatment modalities, increasing awareness and diagnosis, development of disease-modifying osteoarthritis drugs (DMOADs), and government and private funding for research. Major trends in the forecast period include increasing focus on personalized medicine, the emergence of regenerative therapies, the expansion of pain management options, government and regulatory support, and rising demand in emerging markets. For further insights on the Osteoarthritis Therapeutics market, request a sample here

How is the Osteoarthritis Therapeutics market segmented?

The osteoarthritis therapeuticsmarket covered in this report is segmented –
1) Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Other Drug Types
2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies
3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route
4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs
5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-uses
Subsegments:
1) Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products
2) Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors
3) Analgesics: Opioid Analgesics, Non-Opioid Analgesics, Topical Analgesics
4) Corticosteroids: Injectable Corticosteroids, Oral Corticosteroids, Intra-Articular Corticosteroids
5) Other Drug Types: Disease-Modifying Osteoarthritis Drugs (DMOADs), Platelet-Rich Plasma Therapy, Stem Cell Therapy For further insights on the Osteoarthritis Therapeutics market, request a sample here

Which region has the largest share of the Osteoarthritis Therapeutics market? What are the other regions covered in the report?

North America was the largest region in the osteoarthritis therapeutics market in 2022. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Osteoarthritis Therapeutics market, request a sample here.

Who are the major players in the Osteoarthritis Therapeutics market?

What are the key trends in the Osteoarthritis Therapeutics market?

Major trends in the Osteoarthritis Therapeutics market include Innovative Advances In Osteoarthritis Therapeutics With The Launch Of The NITRO Program. For further insights on the Osteoarthritis Therapeutics market, request a sample here.